PFHO
Pacific Health Care Organization, Inc.1.2300
+0.1800+17.1%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
15.74MP/E (TTM)
11.18Basic EPS (TTM)
0.11Dividend Yield
0%Recent Filings
10-K
FY2025 results
Pacific Health Care Organization posted FY2025 revenue of $6.7M, up 11% y/y, with medical case management surging 42% on employee advocate expansion while HCO dipped 2% from lower enrollments. Operating income climbed 17% to $1.0M despite 10% expense growth from legal fees and data costs; net income rocketed 57% to $1.4M boosted by $419K one-time ERC refunds. Cash flow from operations hit $1.2M, funding Treasury bill investments totaling $10M at year-end. Q4 momentum showed in 5% utilization review growth, yet customer terminations loom. Two clients drove 34% of sales. Heavy reliance on few clients threatens stability.
10-Q
Q3 FY2025 results
Pacific Health Care Organization posted Q3 revenue of $1.6M, up 6% y/y yet flat q/q (derived), driven by 40% gains in medical case management and 9% in utilization review, offsetting HCO and bill review dips from a key customer phase-out. Operating income climbed 35% y/y to $205K on leaner salaries, while YTD revenue surged 16% to $5.1M with operating income up 59% to $823K; net income jumped 96% YTD to $1.2M, boosted by $422K ERC other income yet reconciled to $0.09 diluted EPS on 12.8M shares. Cash hit $2.2M, investments $9.8M, operating cash flow $810K YTD. Debt-free. Customer concentration lingers.
8-K
Suits former execs for $1M+
Pacific Health Care Organization's subsidiaries Medex and MMM sued ex-executives David Kim and Darshan Patel on September 16, 2025, alleging breaches of duty, trade secret theft, and unfair practices. Each suit seeks at least $1,000,000 in damages plus punitive awards and injunctions. Lawsuits target competitive harms. Outcomes remain uncertain.
8-K
Board shakeup adds finance pros
Pacific Health Care Organization's board saw Lauren and Kristina Kubota resign effective August 11, 2025, with Lauren also stepping down as Secretary—no disagreements cited. Bruce Everakes, a CPA and business owner holding 702,356 shares, and internal Controller Scott Allen joined the board that day; Allen took on Secretary and Treasurer roles too. Smooth transition bolsters financial expertise.
10-Q
Q2 FY2025 results
Revenues rose 12% y/y to $1.7M in Q2 ended June 30, 2025, driven by 67% growth in medical case management while HCO dipped 20% from a key customer phaseout; operating income climbed 58% y/y to $304K as expenses grew just 5%. A $420K ERC refund boosted other income, lifting net income 195% y/y to $637K ($0.05 diluted EPS, consistent with 12.8M shares). Cash from operations hit $786K YTD, with $2.2M cash and $9.7M Treasury investments at quarter-end. Customer concentration persists.
IPO
Employees
Sector
Industry
ALHC
Alignment Healthcare, Inc.
20.03-0.08
CLOV
Clover Health Investments, Corp
2.64+0.02
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
CVS
CVS Health Corporation
78.29-1.40
MOH
Molina Healthcare Inc
160.88-5.62
MRAI
Marpai, Inc.
0.75-0.01
OSCR
Oscar Health, Inc.
15.71-0.43
PACS
PACS Group, Inc.
34.20-0.55
PNTG
The Pennant Group, Inc.
29.73+0.00
UNH
UnitedHealth Group Incorporated
334.20-6.90